Have a personal or library account? Click to login
Synthesis and antiplasmodial evaluation of novel mefloquine-based fumardiamides Cover

Synthesis and antiplasmodial evaluation of novel mefloquine-based fumardiamides

Acta Pharmaceutica
Volume 69 (2019): Issue 2 (June 2019)
By: Maja Beus,  Diana Fontinha,  Jana Held,  Zrinka Rajić,  Miguel Prudêncio and  Branka Zorc  
Open Access
|Mar 2019

Authors

Maja Beus

University of Zagreb Faculty of Pharmacy and Biochemistry, Department of Medicinal Chemistry, Zagreb, Croatia

Diana Fontinha

Instituto de Medicina Molecular Faculdade de Medicina, Universidade de Lisboa, Lisboa, Portugal

Jana Held

University of Tübingen Institute of Tropical Medicine, Tübingen, Germany

Zrinka Rajić

University of Zagreb Faculty of Pharmacy and Biochemistry, Department of Medicinal Chemistry, Zagreb, Croatia

Miguel Prudêncio

Instituto de Medicina Molecular Faculdade de Medicina, Universidade de Lisboa, Lisboa, Portugal

Branka Zorc

bzorc@pharma.hr

University of Zagreb Faculty of Pharmacy and Biochemistry, Department of Medicinal Chemistry, Zagreb, Croatia
DOI: https://doi.org/10.2478/acph-2019-0019 | Journal eISSN: 1846-9558 | Journal ISSN: 1330-0075
Journal RSS Feed
Language: English
Page range: 233 - 248
Accepted on: Feb 14, 2019
|
Published on: Mar 28, 2019
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
mefloquine,
2,8-bis(trifluoromethyl)quinoline,
fumardiamide,
halogenaniline,
antiplasmodial activity
Related subjects:
Pharmacy,
Pharmacy, other

© 2019 Maja Beus, Diana Fontinha, Jana Held, Zrinka Rajić, Miguel Prudêncio, Branka Zorc, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Previous articleVolume 69 (2019): Issue 2 (June 2019)Next article